Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T26623 | Target Info | |||
Target Name | Aldose reductase (AKR1B1) | ||||
Synonyms | Aldehyde reductase; AKR1B1 | ||||
Target Type | Successful Target | ||||
Gene Name | AKR1B1 | ||||
Biochemical Class | Short-chain dehydrogenases reductase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (R)-Sulindac | Ligand Info | |||
Canonical SMILES | CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O | ||||
InChI | 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-/t25-/m1/s1 | ||||
InChIKey | MLKXDPUZXIRXEP-LQVWSKNFSA-N | ||||
PubChem Compound ID | 16046677 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3U2C Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution | ||||||
Method | X-ray diffraction | Resolution | 1.00 Å | Mutation | No | [1] |
PDB Sequence |
ASRILLNNGA
10 KMPILGLGTW20 KSPPGQVTEA30 VKVAIDVGYR40 HIDCAHVYQN50 ENEVGVAIQE 60 KLREQVVKRE70 ELFIVSKLWC80 TYHEKGLVKG90 ACQKTLSDLK100 LDYLDLYLIH 110 WPTGFKPGKE120 FFPLDESGNV130 VPSDTNILDT140 WAAMEELVDE150 GLVKAIGISN 160 FNHLQVEMIL170 NKPGLKYKPA180 VNQIECHPYL190 TQEKLIQYCQ200 SKGIVVTAYS 210 PLGSPDRPWA220 KPEDPSLLED230 PRIKAIAAKH240 NKTTAQVLIR250 FPMQRNLVVI 260 PKSVTPERIA270 ENFKVFDFEL280 SSQDMTTLLS290 YNRNWRVCAL300 LSCTSHKDYP 310 FHEEF
|
|||||
|
||||||
PDB ID: 3RX3 Crystal Structure of Human Aldose Reductase Complexed with Sulindac | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [2] |
PDB Sequence |
SHMASRLLLN
7 NGAKMPILGL17 GTWKSPPGQV27 TEAVKVAIDV37 GYRHIDCAHV47 YQNENEVGVA 57 IQEKLREQVV67 KREELFIVSK77 LWCTYHEKGL87 VKGACQKTLS97 DLKLDYLDLY 107 LIHWPTGFKP117 GKEFFPLDES127 GNVVPSDTNI137 LDTWAAMEEL147 VDEGLVKAIG 157 ISNFNHLQVE167 MILNKPGLKY177 KPAVNQIECH187 PYLTQEKLIQ197 YCQSKGIVVT 207 AYSPLGSPDR217 PWAKPEDPSL227 LEDPRIKAIA237 AKHNKTTAQV247 LIRFPMQRNL 257 VVIPKSVTPE267 RIAENFKVFD277 FELSSQDMTT287 LLSYNRNWRV297 CALLSCTSHK 307 DYPFHEEF
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An old NSAID revisited: crystal structure of aldose reductase in complex with sulindac at 1.0 ? supports a novel mechanism for its anticancer and antiproliferative effects. ChemMedChem. 2011 Dec 9;6(12):2155-7. | ||||
REF 2 | The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase. FEBS Lett. 2012 Jan 2;586(1):55-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.